The options aren't shell out $30k/year or let people get AIDs. There's a missing third option: don't let drug companies charge so much money, especially when th

The options aren't shell out $30k/year or let people get AIDs. There's a missing third option: don't let drug companies charge so much money, especially when the government paid for the development of the drug!